These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


114 related items for PubMed ID: 6749512

  • 1. Comparative growth of human tumors in pharmacologically immunosuppressed, immune-deprived, cyclosporin A-treated and nude mice.
    Floersheim GL.
    Eur J Cancer Clin Oncol; 1982 Jun; 18(6):589-94. PubMed ID: 6749512
    [Abstract] [Full Text] [Related]

  • 2. Methods of immunosuppression for study of growth and lung colony formation by human tumor cells in mice.
    Kovnat A, Khoo K, Selby P, Tannock I.
    Cancer Res; 1986 Apr; 46(4 Pt 1):1617-22. PubMed ID: 3512076
    [Abstract] [Full Text] [Related]

  • 3. Growth of human tumors in mice after short-term immunosuppression with procarbazine, cyclophosphamide, and antilymphocyte serum.
    Floersheim GL, Nassenstein D, Torhorst J.
    Transplantation; 1980 Oct; 30(4):275-80. PubMed ID: 6934635
    [Abstract] [Full Text] [Related]

  • 4. Human tumour xenografts established and serially transplanted in mice immunologically deprived by thymectomy, cytosine arabinoside and whole-body irradiation.
    Selby PJ, Thomas JM, Monaghan P, Sloane J, Peckham MJ.
    Br J Cancer; 1980 Jan; 41(1):52-61. PubMed ID: 7362779
    [Abstract] [Full Text] [Related]

  • 5. Xenografts in pharmacologically immunosuppressed mice as a model to test the chemotherapeutic sensitivity of human tumors.
    Floersheim GL, Bieri A, Chiodetti N.
    Int J Cancer; 1986 Jan 15; 37(1):109-14. PubMed ID: 3455687
    [Abstract] [Full Text] [Related]

  • 6. Optimal conditions for the growth of malignant human and animal cell populations in immunosuppressed mice.
    Stanbredge EJ, Boulger LR, Franks CR, Garrett JA, Reeson DE, Bishop D, Perkins FT.
    Cancer Res; 1975 Aug 15; 35(8):2203-12. PubMed ID: 1080073
    [Abstract] [Full Text] [Related]

  • 7. Growth pattern of tumor xenografts in Wistar rats after treatment with cyclophosphamide, total lymphoid irradiation and/or cyclosporin A.
    Hoogenhout J, Kazem I, Jerusalem CR, Bakkeren JA, de Jong J, Kal HB, van Munster PJ.
    Int J Radiat Oncol Biol Phys; 1983 Jun 15; 9(6):871-9. PubMed ID: 6575007
    [Abstract] [Full Text] [Related]

  • 8. Improved immune-suppression techniques for the exongrafting of human tumours.
    Steel GG, Courtenay VD, Rostom AY.
    Br J Cancer; 1978 Feb 15; 37(2):224-30. PubMed ID: 343803
    [Abstract] [Full Text] [Related]

  • 9. The suitability of immunosuppressed mice kept in a standard animal unit as recipients of human tumour xenografts.
    Hay JH, Morten JE, Clarke B, Swinton J.
    Lab Anim; 1985 Apr 15; 19(2):119-22. PubMed ID: 3889494
    [Abstract] [Full Text] [Related]

  • 10. Xenografts of human bladder cancer in immune-deprived mice.
    Kovnat A, Armitage M, Tannock I.
    Cancer Res; 1982 Sep 15; 42(9):3696-703. PubMed ID: 7049361
    [Abstract] [Full Text] [Related]

  • 11. Enhancement of heterotransplanted human tumor graft survival in nude mice treated with antilymphocyte serum and in congenitally athymic-asplenic (Lasat) mice.
    Gershwin ME, Ikeda RM, Erickson K, Owens R.
    J Natl Cancer Inst; 1978 Jul 15; 61(1):245-8. PubMed ID: 276631
    [Abstract] [Full Text] [Related]

  • 12. Transplantation of primary explants of human tumour to mice treated with antilymphocyte serum.
    Phillips B, Gazet JC.
    Br J Cancer; 1970 Mar 15; 24(1):92-5. PubMed ID: 5428619
    [Abstract] [Full Text] [Related]

  • 13. Quantitative studies on the transplantability of murine and human tumors into the brain and subcutaneous tissues of NCr/Sed nude mice.
    Zietman AL, Suit HD, Ramsay JR, Silobrcic V, Sedlacek RS.
    Cancer Res; 1988 Nov 15; 48(22):6510-6. PubMed ID: 3052803
    [Abstract] [Full Text] [Related]

  • 14. The effect of the immune status of the TAR mouse on the growth and metastasis of tumour xenografts.
    Buckle AM, Goepel JR, Rees RC.
    Eur J Cancer Clin Oncol; 1987 Jun 15; 23(6):663-74. PubMed ID: 3308478
    [Abstract] [Full Text] [Related]

  • 15. Transfer of immunity by transfer of bone marrow cells: a requirement for T lymphocytes and sensitivity to cyclophosphamide.
    Marusić M.
    Exp Hematol; 1978 Oct 15; 6(9):725-37. PubMed ID: 361429
    [Abstract] [Full Text] [Related]

  • 16. Animal model for small cell carcinoma of the lung. Effect of immunosuppression and sex of mouse on tumor growth in nude athymic mice.
    Pettengill OS, Curphey TJ, Cate CC, Flint CF, Maurer LH, Sorenson GD.
    Exp Cell Biol; 1980 Oct 15; 48(4):279-97. PubMed ID: 6249655
    [Abstract] [Full Text] [Related]

  • 17. Effect of immunosuppression on rejection of cartilage formed by transplanted allogeneic rib chondrocytes in mice.
    Malejczyk J, Osiecka A, Hyc A, Moskalewski S.
    Clin Orthop Relat Res; 1991 Aug 15; (269):266-73. PubMed ID: 1864049
    [Abstract] [Full Text] [Related]

  • 18. The pathological effects of immunosuppression of Schistosoma mansoni-infected mice, with particular reference to survival and hepatotoxicity after thymectomy and treatment with antithymocyte serum, and treatment with hydrocortisone acetate.
    Lucas S, Musallam R, Bain J, Hassounah O, Bickle Q, Doenhoff M.
    Trans R Soc Trop Med Hyg; 1980 Aug 15; 74(5):633-43. PubMed ID: 6971004
    [Abstract] [Full Text] [Related]

  • 19. HeLa cell-tumor in nude mice and its response to antitumor agents.
    Arai T, Okamoto K, Ishiguro K, Terao K.
    Gan; 1976 Aug 15; 67(4):493-503. PubMed ID: 1030674
    [Abstract] [Full Text] [Related]

  • 20. Tumorigenicity of human malignant lymphoblasts: comparative study with unmanipulated nude mice, antilymphocyte serum-treated nude mice, and X-irradiated nude mice.
    Ohsugi Y, Gershwin ME, Owens RB, Nelson-Rees WA.
    J Natl Cancer Inst; 1980 Oct 15; 65(4):715-8. PubMed ID: 6932523
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.